Competition

  • August 06, 2026

    Paramount Gets Private Warner Deal Challenge Tossed

    A California federal court has dismissed a case from consumers looking to undo Paramount's completed merger with Skydance and block its planned purchase of Warner Bros. Discovery, finding they failed to show any concrete harm from the deals.

  • August 06, 2026

    LIV Announces New Investor To Replace Saudis, Plans Return

    LIV Golf said it has struck an agreement with a new investor that will allow the tour to live on after the 2026 season, when Saudi Arabia's Public Investment Fund ends its financial backing.

  • August 06, 2026

    Agri Stats Deals Close Out Pork Trial

    A Minnesota federal judge on Thursday cancelled the looming pork price-fixing trial after the last remaining defendant, Agri Stats, inked settlements in principle with the last remaining plaintiffs.

  • August 06, 2026

    FCC Lifts 39% Broadcast Ownership Cap In Controversial Vote

    The Federal Communications Commission voted 2-1 to eliminate the 39% national cap on broadcast TV audience share Thursday, with Republicans saying the change will help local stations survive and dismissing claims that the agency was exceeding its legal powers.

  • August 06, 2026

    Rising Star: Morgan Lewis' Zachary Johns

    Zachary Johns of Morgan Lewis & Bockius LLP helped hospital network Aspirus escape an illegal monopoly lawsuit by convincing the court the plaintiffs' impact and damages model didn't hold water, earning him a spot among antitrust attorneys under age 40 honored by Law360 as Rising Stars.

  • August 06, 2026

    Shein Eyes $40B Valuation Via Hong Kong IPO, More Rumors

    Fast-fashion company Shein is seeking a $40 billion valuation through its Hong Kong initial public offering, betting platform Polymarket is eyeing a new funding round that could value it at $20 billion and Cencora's MWI Animal Health merger with Covetrus faces regulatory scrutiny.

  • August 06, 2026

    Eli Lilly, Novo Nordisk Antitrust Suit Tossed By Texas Judge

    A Texas federal court has dismissed compounding pharmacy Strive Specialties Inc.'s antitrust lawsuit against Eli Lilly and Novo Nordisk, finding it failed to allege the companies blocked competition for GLP-1 medications.

  • August 06, 2026

    Innsworth Drops Merricks Arbitration Claim After £63M Payout

    Litigation funder Innsworth Capital has dropped its arbitration claim against Walter Merricks over his decision to settle the Mastercard swipe fees case for £200 million ($270 million), clearing the way for compensation to be distributed to consumers.

  • August 06, 2026

    Va. Judge Sinks General Dynamics' Fee Bid For No-Poach Suit

    A Virginia federal judge denied General Dynamics Corp.'s attempt to recoup millions in costs and attorney fees from engineers who dropped claims against the company from a larger suit accusing U.S. shipbuilders of conspiring to suppress wages through no-poach agreements.

  • August 06, 2026

    Judge OKs $35M Teva Deal In Delayed Generic Inhalers Suit

    A Massachusetts federal judge has approved an antitrust settlement that will see Teva Pharmaceuticals pay $35 million to resolve claims that it schemed to delay generic competition for its QVAR asthma inhalers.

  • August 05, 2026

    Grocery Chains Accuse Refined Sugar Cos. Of Price-Fixing

    Several grocery chains, including Albertsons and Kroger, have accused a group of refined sugar companies including Domino Sugar of conspiring to artificially raise the cost of refined sugar through a "give to get" arrangement.

  • August 05, 2026

    Drug Cos. Can't Trim Humana's Price-Fix Claims In Bellwether

    A Pennsylvania federal judge on Tuesday denied a bid by a number of generic drug manufacturers to dismiss two antitrust claims brought by health insurer Humana Inc. from an upcoming bellwether trial in long-running antitrust multidistrict litigation, finding they were brought within the statute of limitations.

  • August 05, 2026

    DOJ Pulls ISS Letter, Signals Possible Antitrust Enforcement

    The Justice Department's Antitrust Division signaled Wednesday that it may take enforcement action against Institutional Shareholder Services, withdrawing a 1987 letter stating the division would not do so and flagging "significant competition concerns" about the concentration of proxy advisory market power.

  • August 05, 2026

    Bang Energy's Ex-CEO Gets Loan Approval To Fund Defense

    A Florida bankruptcy judge approved a loan Wednesday for a company managed by Bang Energy founder Jack Owoc to allow him to fund his defense in litigation filed by the trustee overseeing the energy drinks manufacturer's bankrupt estate.

  • August 05, 2026

    CREXi Wants 9th Circ. To Undo Quinn Emanuel CoStar Row DQ

    Commercial Real Estate Exchange Inc. doesn't want to replace Quinn Emanuel Urquhart & Sullivan LLP after a California federal judge disqualified the firm from defending a copyright infringement suit by CoStar, seeking Ninth Circuit intervention and a pause on the district court case.

  • August 05, 2026

    Takeda Says Rebates, Subsidies Cut $885M IBS Drug Verdict

    Takeda Pharmaceuticals battled with a class of health plans over whether a Massachusetts federal jury's $885 million antitrust verdict against the drugmaker for conspiring to delay generic competition to anticonstipation drug Amitiza should be reduced by rebates the drugmaker paid and Medicare subsidies that reduced the health plans' costs.

  • August 05, 2026

    Judge Tosses 'Free' Wi-Fi Calling Fraud Claim Against Carriers

    A D.C. federal judge blasted a Wi-Fi-calling patent holder's antitrust and RICO suit against the major telecom carriers in court Wednesday, dismissing claims that the carriers misled consumers about their Wi-Fi calling offerings, but he did give the plaintiff a chance to refile its antitrust complaint.

  • August 05, 2026

    Judge Backs Magistrate Judge's Order On 3rd-Party NIL Deals

    A California federal judge said she won't reverse a magistrate judge's decision rejecting a bid by college athletes seeking to limit oversight of third-party name, image and likeness deals under their landmark $2.78 billion class settlement with the NCAA.

  • August 05, 2026

    Senate Panel Presses DOJ Antitrust Pick On Independence

    President Donald Trump's pick to lead the U.S. Department of Justice's Antitrust Division, Adam Candeub, faced tough questions Wednesday during a U.S. Senate confirmation hearing, where several Democrats challenged his independence.

  • August 05, 2026

    Aetna, Others Hit Pharma Cos. With Xifaxan Pay-To-Delay Suit

    Health insurance companies Aetna Inc., Health Care Service Corp. and Molina Inc. have sued multiple pharmaceutical companies in Pennsylvania state court in Pittsburgh, alleging that the defendants conspired to delay the release of generic versions of the irritable bowel syndrome drug Xifaxan, in violation of antitrust laws.

  • August 05, 2026

    Conn. Atty To Fork Over $3,500 For AI Errors In Taco TM Beef

    A Connecticut federal judge imposed a $3,500 fine on a defense attorney who submitted two motions riddled with AI-generated mistakes in a taco restaurant's trademark battle, finding that although the lawyer expressed remorse and promised to make changes to his verification process, he still showed "subjective bad faith."

  • August 05, 2026

    Rising Star: Simpson Thacher's Lindsey Bohl

    Lindsey Bohl of Simpson Thacher & Bartlett LLP served as second chair in a bench trial that defeated the Federal Trade Commission's bid to block a $5 billion mattress industry merger and brokered a settlement that cleared the way for a $3.3 billion home health company acquisition, earning her a spot among the competition attorneys under age 40 honored by Law360 as Rising Stars.

  • August 05, 2026

    Revive Rx Can't End Eli Lilly's Suit Over Tirzepatide Drugs

    A Texas federal judge has denied Revive Rx's bid to end Eli Lilly and Co.'s remaining unfair competition claims over the compounding pharmacy's sales of allegedly unapproved tirzepatide weight loss drugs that Eli Lilly says compete with Mounjaro and Zepbound, rejecting Revive's argument that compounded drugs fall outside state "new drug" laws.

  • August 05, 2026

    Fed. Circ. Told Injunction Against Samsung Is Warranted

    Collision Communications Inc. wants the Federal Circuit to undo a Texas federal judge's decision denying its bid to block Samsung from selling products a jury found were infringing, saying the judge "went inexplicably astray" following the $445 million verdict.

  • August 05, 2026

    Google £5B Search Ads Class Action Gets Green Light

    Google will face an estimated £5 billion ($7 billion) opt-out class action over allegations it inflated search advertising prices, as the Competition Appeal Tribunal ruled Wednesday that the case can proceed on behalf of almost 900,000 U.K. advertisers.

Expert Analysis

  • FTC-Deere Deal Tells Cautionary Tale On Repair Access Limits

    Author Photo

    A recent proposed Federal Trade Commission antitrust settlement in Illinois federal court requires Deere & Co. to provide access to repair services previously available only to authorized dealers, and companies that limit access to aftermarket resources should ensure they can substantiate the reasoning behind any restrictions, say attorneys at Freshfields.

  • Series

    Being A Sommelier Makes Me A Better Lawyer

    Author Photo

    Being a sommelier has quietly shaped how I practice law by changing the way I think, communicate and connect with people, and offers a constant reminder that expertise is about making your knowledge useful and accessible to others, says Kara Du at Sheppard.

  • Card Grading Merger Suit Tests Antitrust In Niche Market

    Author Photo

    Rasmussen v. Collectors Holdings, a class action pending in California federal court challenging the effects of a trading card grading company merger, reflects the elevation of trading cards from hobby collectibles to niche investment markets susceptible to classic antitrust injury theories, say attorneys at Kean Miller.

  • Why A Class Was Certified In Financial Aid Info-Sharing Case

    Author Photo

    The recent Illinois federal court decision in Corzo v. Brown University offers key guidance for defendants confronting class certification in antitrust matters, highlighting how typicality can be satisfied despite class members attending different universities, receiving different aid awards and being affected across different time periods, say attorneys at Baker McKenzie.

  • FTC Focus: Enforcing Vertically Integrated Operating Systems

    Author Photo

    As digital platforms increasingly pair operating systems with commerce, advertising, content and data, antitrust scrutiny will turn on whether those integrations create private bottlenecks that foreclose rivals through access, ranking, interoperability or defaults, pushing courts and enforcement agencies to adapt traditional utility and merger frameworks more aggressively, say attorneys at Proskauer.

  • China's New Outbound Investment Rule Reshapes Deal Risk

    Author Photo

    China's new outbound investment regulation introduces broad national security review and penalties, including personal liability, that will necessitate deeper diligence of cross-border deal participants with Chinese ties, earlier regulatory planning and closer attention to sanctions exposure, say attorneys at Freshfields.

  • A Shift In How Policymakers Are Approaching PBM Regulation

    Author Photo

    Recent federal and state legislative and regulatory activity involving pharmacy benefit managers represent a change in focus from transparency to PBM compensation structures, vertical integration and competitive effects, say attorneys at Barclay Damon.

  • How State Actions Are Reshaping Surveillance Pricing Risk

    Author Photo

    Amid heightened state enforcement activity and expanding legislative action to curb surveillance pricing concerns related to transparency, fairness and discrimination, businesses should closely examine how consumer data is used in pricing decisions, say attorneys at Steptoe.

  • Opinion

    States Should Reconsider Forced PBM Divestiture Laws

    Author Photo

    State legislatures are attempting to enact policies intended to force pharmacy benefit managers to divest from pharmacies, but these laws would have the practical effect of reducing patient access and competition, potentially violating the U.S. Constitution in the process, says former Utah Attorney General John Swallow.

  • HSR Deals Proceed More Steadily Than Narratives Suggest

    Author Photo

    The most recent Hart-Scott-Rodino Act data show that transaction volume remained relatively stable, transaction values continued to increase and enforcement activity remained low, suggesting that enforcement rates have been relatively consistent across presidential administrations despite widely differing public rhetoric regarding merger enforcement, says Amanda Wait at Michael Best.

  • Series

    Teaching SEC Investigations Makes Me A Better Lawyer

    Author Photo

    Instructing a law school course on U.S. Securities and Exchange Commission investigations has made me a more thoughtful, deliberate practitioner because it requires me to continually reassess and challenge what I know about securities law enforcement, how I know it and how best to explain it, says David Chase at Miami Law.

  • Noncompete Laws Show States Focusing On Bans, Healthcare

    Author Photo

    The first half of 2026 confirms that state legislatures are driving the most consequential changes in noncompete law, including a few state bans and several healthcare-specific laws, making a one-size-fits-all approach increasingly untenable for multistate employers, say attorneys at Faegre Drinker.

  • And Now A Word From The Panel: MDL Judge Selection

    Author Photo

    To understand how the Judicial Panel on Multidistrict Litigation selects particular judges to preside over MDL proceedings, it helps to consider not only how much experience on the federal bench a judge has, but also whether they have specifically managed any prior MDLs, says Alan Rothman at Sidley Austin.

  • Assessing DOJ Antitrust's New, Faster Merger Review Option

    Author Photo

    The U.S. Justice Department Antitrust Division's recently announced targeted second request option and new model timing signal a commercially friendly stance and a departure from the prior administration's position, say attorneys at Paul Weiss.

  • Series

    Judges On AI: Examining Administrative, Organizational Uses

    Author Photo

    U.S. District Judge Alan Albright of the Western District of Texas examines how artificial intelligence could transform a court's ability to deal with administrative work and organize materials when preparing for hearings or drafting opinions, thereby affording judges more time to resolve contested issues.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here